Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in CGTX — Cognition Therapeutics Inc

CIK 72971 SAN FRANCISCO, CA
Back to CGTX Full portfolio

Position in CGTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,450
+$1,132 QoQ
Shares Held
3,000
-1.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 66 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 67% Shared 0% None 33%

Common Shares in CGTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. CGTX ranks #347 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in CGTX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,450 3,000
2026-03-31 $2,318 3,050
2025-12-31 $4,050 3,000
2025-09-30 $5,400 4,000
2025-06-30 $310 1,000
2025-03-31 $421 1,000
2024-12-31 $701 1,000
2024-09-30 $469 1,000
2024-06-30 $1,660 1,000
2024-03-31 $265 146
2023-12-31 $251 136
2023-09-30 $184 128
2023-06-30 $250 137
2023-03-31 $245 124
2022-12-31 $80,871 38,510
2022-09-30 $146,161 76,927
2022-06-30 $162,188 76,867
2022-03-31 $66 24
2021-12-31 $151 24